Pediatric Vaccines Market Size, Share, Trends, Growth Outlook

Pediatric Vaccines Market is estimated to increase at a growth rate of 10.2% CAGR over the forecast period from 2024 to 2030.

The global Pediatric Vaccines Marketstudy analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments including By Vaccine (Monovalent, Multivalent), By Technology (Live Attenuated, Inactivated, Toxoid, Conjugate, Others), By Application (Pneumococcal Disease, Influenza, Measles, Mumps, and Rubella (MMR), Others).

An introduction to Pediatric Vaccines Market in 2024

Safeguarding children against infectious diseases and promoting public health, the Pediatric Vaccines Market offers a portfolio of preventive vaccines targeting viral, bacterial, and parasitic pathogens responsible for childhood illnesses such as measles, polio, influenza, and pneumococcal disease. Pediatric vaccines include routine childhood immunizations recommended by national vaccination schedules, as well as newer vaccines addressing emerging infectious disease threats and vaccine-preventable diseases of global concern. The market's growth is driven by expanding vaccination coverage, government immunization programs, and advancements in vaccine technology enabling the development of safer, more effective, and combination vaccines improving pediatric vaccine uptake, coverage rates, and disease eradication efforts worldwide.

Pediatric Vaccines market Trend: Expansion of Vaccination Programs and Immunization Initiatives

A significant trend in the Pediatric Vaccines market is the expansion of vaccination programs and immunization initiatives. Governments, public health organizations, and healthcare providers worldwide are increasingly emphasizing the importance of childhood immunization as a cornerstone of preventive healthcare. There's a growing focus on implementing comprehensive vaccination schedules, increasing vaccine coverage rates, and introducing new vaccines to protect children against a broader range of infectious diseases. Additionally, initiatives such as the Global Vaccine Action Plan and the Expanded Program on Immunization aim to improve vaccine access, affordability, and delivery infrastructure in low- and middle-income countries, driving growth and demand in the pediatric vaccines market.

Pediatric Vaccines market Driver: Rising Awareness of Vaccine-Preventable Diseases and Outbreaks

The primary driver in the Pediatric Vaccines market is the rising awareness of vaccine-preventable diseases and outbreaks. Despite significant progress in reducing the burden of infectious diseases through vaccination, outbreaks of vaccine-preventable diseases such as measles, pertussis, and influenza continue to occur globally, posing public health threats and highlighting the importance of vaccination in disease prevention and control. High-profile outbreaks, coupled with increased access to information through media and digital channels, have contributed to heightened awareness among parents, healthcare providers, and policymakers about the importance of childhood immunization. This increased awareness drives demand for pediatric vaccines and vaccination services, fueling market growth in the pediatric vaccines segment.

Pediatric Vaccines market Opportunity: Development of Next-Generation Vaccines and Vaccine Technologies

One potential opportunity in the Pediatric Vaccines market is the development of next-generation vaccines and vaccine technologies. With advancements in immunology, vaccinology, and biotechnology, there's a growing opportunity to innovate and improve existing vaccines or develop novel vaccines against emerging infectious diseases and pathogens. Manufacturers and biopharmaceutical companies can capitalize on this opportunity by investing in research and development of new vaccine platforms, such as mRNA vaccines, viral vector vaccines, and recombinant protein vaccines, that offer enhanced immunogenicity, improved safety profiles, and broader coverage against multiple strains or serotypes. By developing next-generation vaccines tailored to the evolving needs of pediatric populations, companies can address unmet medical needs, expand their product portfolios, and drive innovation and growth in the pediatric vaccines market.

Pediatric Vaccines Market Market Segmentation

By Vaccine
Monovalent
Multivalent
By Technology
Live Attenuated
Inactivated
Toxoid
Conjugate
Others
By Application
Pneumococcal Disease
Influenza
Measles, Mumps, and Rubella (MMR)
Others

Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)

Pediatric Vaccines Market Companies

AstraZeneca plc
GlaxoSmithKline PLC
Indian Immunologicals Ltd
Merck & Co. Inc
Mitsubishi Tanabe Pharma Corp
Novavax Inc
Pfizer Inc
Sanofi SA
Seqirus
Sinovac Biotech Ltd

Reasons to Buy the Pediatric Vaccines Market Study

• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Pediatric Vaccines Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Pediatric Vaccines Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.

TABLE OF CONTENTS

1 Introduction to 2024 Pediatric Vaccines Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Analyzed
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain

2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations

3 Executive Summary
3.1 Global Pediatric Vaccines Market Size Outlook, $ Million, 2021 to 2030
3.2 Pediatric Vaccines Market Outlook by Type, $ Million, 2021 to 2030
3.3 Pediatric Vaccines Market Outlook by Product, $ Million, 2021 to 2030
3.4 Pediatric Vaccines Market Outlook by Application, $ Million, 2021 to 2030
3.5 Pediatric Vaccines Market Outlook by Key Countries, $ Million, 2021 to 2030

4 Market Dynamics
4.1 Key Driving Forces of Pediatric Vaccines Industry
4.2 Key Market Trends in Pediatric Vaccines Industry
4.3 Potential Opportunities in Pediatric Vaccines Industry
4.4 Key Challenges in Pediatric Vaccines Industry

5 Market Factor Analysis
5.1 Value Chain Analysis
5.2 Competitive Landscape
5.2.1 Global Pediatric Vaccines Market Share by Company (%), 2023
5.2.2 Product Offerings by Company
5.3 Porter’s Five Forces Analysis
5.4 Pricing Analysis and Outlook

6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts

7 Global Pediatric Vaccines Market Outlook by Segments
7.1 Pediatric Vaccines Market Outlook by Segments, $ Million, 2021- 2030
By Vaccine
Monovalent
Multivalent
By Technology
Live Attenuated
Inactivated
Toxoid
Conjugate
Others
By Application
Pneumococcal Disease
Influenza
Measles, Mumps, and Rubella (MMR)
Others

8 North America Pediatric Vaccines Market Analysis and Outlook To 2030
8.1 Introduction to North America Pediatric Vaccines Markets in 2024
8.2 North America Pediatric Vaccines Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Pediatric Vaccines Market size Outlook by Segments, 2021-2030
By Vaccine
Monovalent
Multivalent
By Technology
Live Attenuated
Inactivated
Toxoid
Conjugate
Others
By Application
Pneumococcal Disease
Influenza
Measles, Mumps, and Rubella (MMR)
Others

9 Europe Pediatric Vaccines Market Analysis and Outlook To 2030
9.1 Introduction to Europe Pediatric Vaccines Markets in 2024
9.2 Europe Pediatric Vaccines Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Pediatric Vaccines Market Size Outlook by Segments, 2021-2030
By Vaccine
Monovalent
Multivalent
By Technology
Live Attenuated
Inactivated
Toxoid
Conjugate
Others
By Application
Pneumococcal Disease
Influenza
Measles, Mumps, and Rubella (MMR)
Others

10 Asia Pacific Pediatric Vaccines Market Analysis and Outlook To 2030
10.1 Introduction to Asia Pacific Pediatric Vaccines Markets in 2024
10.2 Asia Pacific Pediatric Vaccines Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Pediatric Vaccines Market size Outlook by Segments, 2021-2030
By Vaccine
Monovalent
Multivalent
By Technology
Live Attenuated
Inactivated
Toxoid
Conjugate
Others
By Application
Pneumococcal Disease
Influenza
Measles, Mumps, and Rubella (MMR)
Others

11 South America Pediatric Vaccines Market Analysis and Outlook To 2030
11.1 Introduction to South America Pediatric Vaccines Markets in 2024
11.2 South America Pediatric Vaccines Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Pediatric Vaccines Market size Outlook by Segments, 2021-2030
By Vaccine
Monovalent
Multivalent
By Technology
Live Attenuated
Inactivated
Toxoid
Conjugate
Others
By Application
Pneumococcal Disease
Influenza
Measles, Mumps, and Rubella (MMR)
Others

12 Middle East and Africa Pediatric Vaccines Market Analysis and Outlook To 2030
12.1 Introduction to Middle East and Africa Pediatric Vaccines Markets in 2024
12.2 Middle East and Africa Pediatric Vaccines Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Pediatric Vaccines Market size Outlook by Segments, 2021-2030
By Vaccine
Monovalent
Multivalent
By Technology
Live Attenuated
Inactivated
Toxoid
Conjugate
Others
By Application
Pneumococcal Disease
Influenza
Measles, Mumps, and Rubella (MMR)
Others

13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
AstraZeneca plc
GlaxoSmithKline PLC
Indian Immunologicals Ltd
Merck & Co. Inc
Mitsubishi Tanabe Pharma Corp
Novavax Inc
Pfizer Inc
Sanofi SA
Seqirus
Sinovac Biotech Ltd
14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise

By Vaccine
Monovalent
Multivalent
By Technology
Live Attenuated
Inactivated
Toxoid
Conjugate
Others
By Application
Pneumococcal Disease
Influenza
Measles, Mumps, and Rubella (MMR)
Others